Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Emergis Inc. (EME-T-DEAD)

DON'T BUY
It's difficult to know to what extent B.C.E. is going to support them. Too new for them to look at.
DON'T BUY
Like it as a concept stock but has been very disappointing. Has not been winning contracts. Considering selling their holdings.
HOLD
Last quarter indicates they are on track. Not showing substantial growth. Need to see expansion of their lines, particularly in the financial and health-care areas. Want to see more profitability.
DON'T BUY
Some contracts have been reduced or they are being squeezed on price. An interesting play, but would prefer playing this through BCE which gives you exposure plus you hold Bell shares.
DON'T BUY
In the bottom 3% of the database. Forecasted to have pretty good earnings next year. The stock price is not reflecting this.
BUY
Earnings were a little bit soft. Hurt by Cdn$. Sees some upside. Profitable now.
DON'T BUY
Their numbers were disappointing. The contract with BCE is declining substantially.
DON'T BUY
Volatile. Making some money. Risky. Wireless technology could be trouble for them.
DON'T BUY
Ranks in the bottom 10% of the database. Overall return on investment forcasted earnings of $0.23 is only about 4%. The big contract with BCE is slowly winding down.
WEAK BUY
OK for the long term. Field has to grow.
BUY
New managemtn and new vision. On a 5 year time horizon, it should do well.
HOLD
Wait for build out of contracts. Should have some upside.
DON'T BUY
The group has been firming up recently. Hasn't been the leader in their sctor.
DON'T BUY
Not sure how their business plan will make any money.
DON'T BUY
No earnings.
Showing 31 to 45 of 168 entries